Alcohol consumption is inversely associated with stage 3 chronic kidney disease in middle-aged Taiwanese men

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Hsu, Yueh Han ^a,b,c   Pai, Hsiang Chu ^c   Chang, Yao Mao ^d   Liu, Wen Hsin ^b   Hsu, Chih Cheng ^a,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c MIN HWEI COLLEGE OF HEALTH CARE MANAGEMENT   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Alcohol consumption; Chronic kidney disease; Gender; Proteinuria; Taiwan

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ANEMIA; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK BEHAVIOR; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MIDDLE AGED; PROTEINURIA; SELF REPORT; TAIWAN;

AGE DISTRIBUTION; ALCOHOL DRINKING; CAUSALITY; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEN'S HEALTH; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEX DISTRIBUTION; SMOKING; STATISTICS AS TOPIC; TAIWAN;

EID: 84887506284     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-254     Document Type: Article

References (41)

1. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS, JAMA 2007 298 2038 2047 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
2. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC, J Am Soc Nephrol 2003 14 131 S138 10.1097/01.ASN.0000070152.11927.4A 12819318
3. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Hsu CC, Hwang SJ, Wen CP, Chang HY, Chen T, Shiu RS, Horng SS, Chang YK, Yang WC, Am J Kidney Dis 2006 48 727 738 10.1053/j.ajkd.2006.07.018 17059992 (Pubitemid 44740043)
4. United States Renal Data System (USRDS) 2012 Annual Data Report [ http://www.usrds.org/2012/pdf/v2-ch12-12.pdf ]
5. High risk of renal failure in stage 3B chronic kidney disease is under-recognized in standard medical screening. Wu MJ, Shu KH, Liu PH, Chiang PH, Cheng CH, Chen CH, Yu DM, Chuang YW, J Chin Med Assoc 2010 73 515 522 10.1016/S1726-4901(10)70113-1 21051028
6. Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Tanaka K, Hara S, Kushiyama A, Ubara Y, Yoshida Y, Mizuiri S, Aikawa A, Kawatzu S, Clin Exp Nephrol 2011 15 391 397 10.1007/s10157-011-0420-6 21331740
7. Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Ito S, Naritomi H, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N, Hypertens Res 2012 35 867 873 10.1038/hr.2012.59 22573200
8. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH, Arch Intern Med 2004 164 659 663 10.1001/archinte.164.6.659 15037495 (Pubitemid 38392981)
9. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
10. WHO, Global status report on alcohol and health 2011 Geneva: World Health Organization 2011 37 41
11. Risk of end-stage renal disease associated with alcohol consumption. Perneger TV, Whelton PK, Puddey IB, Klag MJ, Am J Epidemiol 1999 150 1275 1281 10.1093/oxfordjournals.aje.a009958 10604769
12. The association among smoking, heavy drinking, and chronic kidney disease. Shankar A, Klein R, Klein BE, Am J Epidemiol 2006 164 263 271 10.1093/aje/kwj173 16775042 (Pubitemid 44289047)
13. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ, Nephrol Dial Transplant 2009 24 2464 2472 10.1093/ndt/gfp114 19307230
14. Relation of alcohol and cigarette consumption to blood pressure and serum creatinine levels. Savdie E, Grosslight GM, Adena MA, J Chronic Dis 1984 37 617 623 10.1016/0021-9681(84)90111-5 6746851 (Pubitemid 14094651)
15. Management of chronic kidney disease: primary health-care setting, self-care and multidisciplinary approach. Cueto-Manzano AM, Martinez-Ramirez HR, Cortes-Sanabria L, Clin Nephrol 2010 74 99 104
16. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Schaeffner ES, Kurth T, de Jong PE, Glynn RJ, Buring JE, Gaziano JM, Arch Intern Med 2005 165 1048 1053 10.1001/archinte.165.9.1048 15883245 (Pubitemid 40638127)
17. Alcohol consumption and the risk of end-stage renal disease among Chinese men. Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, Chen CS, Wu X, Hamm LL, He J, Kidney Int 2008 73 870 876 10.1038/sj.ki.5002774 18185503 (Pubitemid 351398282)
18. Epidemiology of betel quid usage. Gupta PC, Ray CS, Ann Acad Med Singapore 2004 33 31 36 15389304
19. A study on betel quid chewing behavior among Kaohsiung residents aged 15 years and above. Chen JW, Shaw JH, J Oral Pathol Med: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1996 25 140 143 10.1111/j.1600-0714.1996.tb00209.x
20. Association of betel nut chewing with chronic kidney disease: a retrospective 7-year study in Taiwan. Hsu YH, Liu WH, Chen W, Kuo YC, Hsiao CY, Hung PH, Jong IC, Chiang PC, Hsu CC, Nephrology (Carlton) 2011 16 751 757 10.1111/j.1440-1797.2011.01489.x 21736664
21. Chewing areca nut as an independent risk factor for proteinuria in middle-aged men. Liu WH, Hsu CC, Hsu YH, Kaohsiung J Med Sci 2013 29 214 220 10.1016/j.kjms.2012.08.037 23541267
22. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation, Am J Kidney Dis 2002 39 1 S266 11904577
23. Gout and hyperuricemia. Wortmann RL, Kelley WN, Textbook of Rheumatology Philadelphia: W.B. Saunders, Kelley WN, Harris ED, Ruddy S, Sledge CB, 7 2005 1402 1448
24. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A, Kidney Int 2007 71 159 166 10.1038/sj.ki.5002017 17136030 (Pubitemid 46094690)
25. Rat kidney antioxidant response to long-term exposure to flavonol rich red wine. Rodrigo R, Rivera G, Orellana M, Araya J, Bosco C, Life Sci 2002 71 2881 2895 10.1016/S0024-3205(02)02140-9 12377269
26. Effects of chronic ethanol consumption on extramitochondrial fatty acid oxidation and ethanol metabolism by rat kidney. Orellana M, Valdes E, Fernandez J, Rodrigo R, Gen Pharmacol 1998 30 719 723 10.1016/S0306-3623(97)00342-X 9559324 (Pubitemid 28167775)
27. Superoxide dismutase (EC 1.15.1.1), manganese and the effect of ethanol in adult and foetal rats. Dreosti IE, Manuel SJ, Buckley RA, Br J Nutr 1982 48 205 210 10.1079/BJN19820106 6889437 (Pubitemid 13240159)
28. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. Giovannini L, Migliori M, Longoni BM, Das DK, Bertelli AA, Panichi V, Filippi C, Bertelli A, J Cardiovasc Pharmacol 2001 37 262 270 10.1097/00005344-200103000-00004 11243416 (Pubitemid 32193504)
29. Protective effect of quercetin on renal ischemia/reperfusion injury in rats. Kahraman A, Erkasap N, Serteser M, Koken T, J Nephrol 2003 16 219 224 12768068 (Pubitemid 37304078)
30. Cardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu heart program. Burchfiel CM, Tracy RE, Chyou PH, Strong JP, Arterioscler Thromb Vasc Biol 1997 17 760 768 10.1161/01.ATV.17.4.760 9108792 (Pubitemid 27169140)
31. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Shigematsu S, Ishida S, Hara M, Takahashi N, Yoshimatsu H, Sakata T, Korthuis RJ, Free Radic Biol Med 2003 34 810 817 10.1016/S0891-5849(02)01430-2 12654468 (Pubitemid 36316064)
32. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH, N Engl J Med 1993 329 1829 1834 10.1056/NEJM199312163292501 8247033 (Pubitemid 23360481)
33. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH, JAMA 1994 272 929 933 10.1001/jama.1994. 03520120039028 7794308 (Pubitemid 24288546)
34. Relation of drinking alcohol to atherosclerotic risk in type 2 diabetes. Wakabayashi I, Kobaba-Wakabayashi R, Masuda H, Diabetes Care 2002 25 1223 1228 10.2337/diacare.25.7.1223 12087023 (Pubitemid 41071176)
35. Accuracy of self-reported drinking: observational verification of 'last occasion' drink estimates of young adults. Northcote J, Livingston M, Alcohol Alcohol 2011 46 709 713 10.1093/alcalc/agr138 21949190
36. The assessment of alcohol consumption by a simple self-administered questionnaire. Giovannucci E, Colditz G, Stampfer MJ, Rimm EB, Litin L, Sampson L, Willett WC, Am J Epidemiol 1991 133 810 817 2021148
37. Alcohol: role in the development of hypertension and end-stage renal disease. Parekh RS, Klag MJ, Curr Opin Nephrol Hypertens 2001 10 385 390 10.1097/00041552-200105000-00014 11342802 (Pubitemid 32424028)
38. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, Grunfeld JP, Lash JP, McGill JB, Mitch WE, Remuzzi G, et al. Clin J Am Soc Nephrol 2006 1 761 767 10.2215/CJN.01381005 17699284
39. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD, Kidney Int 2004 66 1131 1138 10.1111/j.1523-1755.2004.00863.x 15327408 (Pubitemid 39121019)
40. Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. See LC, Kuo CF, Chuang FH, Shen YM, Ko YS, Chen YM, Yu KH, Clinical rheumatology 2011 30 323 330 10.1007/s10067-010-1461-z 20411291
41. The 2010 Canadian hypertension education program recommendations for the management of hypertension: part 2-therapy. Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, et al. Can J Cardiol 2010 26 249 258 10.1016/S0828-282X(10)70379-2 20485689